METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF BCMAXCD3 BISPECIFIC ANTIBODIES | Patent Publication Number 20230272102

US 20230272102 A1
Patent Number-
Application Number18052174
Filled DateNov 2, 2022
Priority DateNov 3, 2021
Publication DateAug 31, 2023
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsBrendan Weiss
Jenna Goldberg
Raluca Verona
Jagoda Jasielec
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.